✦ LIBER ✦

SUPPRESSION OF PANCREATIC ENDOCRINE TUMOUR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOGUE

✍ Scribed by Long, R.G.; Adrian, T.E.; Brown, M.R.; Rivier, J.E.; Barnes, A.J.; Mallinson, C.N.; Vale, W.; Christofides, N.D.; Bloom, S.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of human exocrine pancreatic

✍ T. P. KEMMER; P. MALFERTHEINER; M. BÜCHLER; H. FRIESS; L. MESCHENMOSER; H. DITSC 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

LONG-ACTING AND SELECTIVE SUPPRESSION OF

✍ Plewe, G.; Krause, U.; Beyer, J.; Neufeld, M.; del Pozo, E. 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 389 KB

Treatment of malignant endocrine pancrea

✍ B. Eriksson; K. Öberg; T. Andersson; G. Lundqvist; L. Wide; E. Wilander 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Vapreotide, a long-acting somatostatin a

✍ Hildebrand, Pius; Nair, Gayathri; Ketterer, Sylvia; Beglinger, Christoph; Aeschl 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 185 KB

TREATMENT OF METASTASISING GRF-PRODUCING

✍ Werder, KlausVon; Losa, Marco; Müller, O.Albrecht; Schweiberer, Leonhard; Fahlbu 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 396 KB

Clinical and hormonal effects of a long-

✍ Jean-Christophe Souquet; Geneviève Sassolas; Jacques Forichon; Pascal Champetier 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB